SCYNEXIS INC
SCYXNASDAQ🏆 #4398 by market capUS Equity
$3.91▲ $0.10 (+2.62%)
Pre-market · at closeTrack SCYX
Get earnings, price moves & breaking news on Telegram
24h▲ 2.6%
7d▲ 2.6%
14d▲ 0.8%
30d▼ 15.8%
ytd▼ 21.7%
1y▼ 28.9%
🏦Market Cap
$39M
Small Cap
📈Revenue Growth (YoY)
489.8%
High Growth
📊Gross Margin
100.0%
High
💵FCF Margin
95.8%
Strong
⚖️P/S Ratio
2.0x
Cheap
Otter Score
—
Insufficient data
Trading Snapshot
- Day Range
- $3.88 – $3.93
- 52-Week Range
- $3.53 – $9.12
- Volume (shares)
- 1,649
- Avg Volume (shares)
- —
- Shares Outstanding
- 9.9M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- $21M
- Last Q Revenue
- $235,000
- P/E Ratio
- —
- P/S Ratio
- 2.0x
- EPS (TTM)
- $-2.16
- Dividend Yield
- —
- Dilution (1yr)
- +14.7%
SCYNEXIS INC
SCYXFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$21M▲ +449.9% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
100.0%▲ +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$16M▼ −56.7% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$5M▼ −78.0% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
5.4M▲ +14.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$19M▲ +$19M YoY
StockOtter · stockotter.spaceAbout SCYNEXIS INC
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.
Latest News & Updates
News unavailable.